Novo Nordisk again raises bid in battle for obesity start-up Metsera
Danish company vies with Pfizer for control of US biotech as they seek edge in growing market for weight-loss drugs
Danish company vies with Pfizer for control of US biotech as they seek edge in growing market for weight-loss drugs
Pfizer had struck deal in September to buy obesity-focused biotech
FTC fast-tracks antitrust approval of earlier deal in sign Washington could weigh in on takeover battle with Novo Nordisk
Biotech says it opted for revised offer from US pharma company after rival Novo bid raised antitrust concerns
Federal Trade Commission wants to ensure bid for weight-loss biotech addresses competition concerns
Danish drugmaker expects sales and profit growth at lower end of its guidance this year
Deal would be the biggest by a large pharma company buying a foothold in the lucrative weight-loss drug market
